Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

9.87
+0.51005.45%
Pre-market: 10.160.2900+2.94%08:47 EDT
Volume:19.69M
Turnover:191.58M
Market Cap:4.47B
PE:-13.98
High:9.93
Open:9.45
Low:9.44
Close:9.36
52wk High:9.93
52wk Low:1.76
Shares:452.97M
Float Shares:394.00M
Volume Ratio:1.47
T/O Rate:5.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7058
EPS(LYR):-1.0941
ROE:-40.36%
ROA:-20.31%
PB:6.07
PE(LYR):-9.02

Loading ...

Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K/A [Amend] - Current report
Jan 23, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 29, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 13, 2022

Major Issues Report

8-K - Current report
May 26, 2022

Major Issues Report

8-K - Current report